iThe current values are delayed, open demat account for live values.
Nifty Pharma
Nifty Pharma Performance
-
Open
21,245.60
-
High
21,485.30
-
Low
21,198.50
-
Prev Close
21,163.90
-
Dividend Yeild
0.63%
-
P/E
33.28
Nifty Pharma Chart
Stocks Performance
Color code for Stocks Performance
- 5% and above
- 5% to 2%
- 2% to 0.5%
- 0.5% to -0.5%
- -0.5% to -2%
- -2% to -5%
- -5% and below
Constituent Companies
| Company | Market Cap | Market Price | Volume | Sector |
|---|---|---|---|---|
| Abbott India Ltd | ₹55452 Cr |
₹26129.4
(1.57%)
|
10374 | Pharmaceuticals |
| Cipla Ltd | ₹117762 Cr |
₹1457.45
(0.89%)
|
1950885 | Pharmaceuticals |
| J B Chemicals & Pharmaceuticals Ltd | ₹27119 Cr |
₹1738.2
(0.7%)
|
175346 | Pharmaceuticals |
| Dr Reddys Laboratories Ltd | ₹99705 Cr |
₹1194.5
(0.67%)
|
2209989 | Pharmaceuticals |
| Lupin Ltd | ₹94192 Cr |
₹2064.4
(0.39%)
|
950195 | Pharmaceuticals |
Nifty Pharma Sector Performance
Top Performing
| Sector Name | Percentage Change |
|---|---|
| IT - Hardware | 1.83 |
| Leather | 1.31 |
| Healthcare | 0.27 |
| Dry cells | 0.67 |
Under Performing
| Sector Name | Percentage Change |
|---|---|
| Diamond, Gems and Jewellery | -0.23 |
| Ceramic Products | -0.26 |
| IT - Software | -0.28 |
| Stock/ Commodity Brokers | -0.21 |
Nifty Pharma
The pharma industry’s performance is depicted in the Nifty Pharma Index. 20 NSE-listed companies are included in the Index (NSE).
The level of the Nifty Pharma Index shows the overall free float market valuation of all the companies included in the benchmark with a specific base market cap value. This index is calculated by using the free float market capitalization approach.
The Nifty Pharma Index is utilized for several things, including creating structured products, ETFs, and index funds, as well as benchmarking investment portfolios.
The index was introduced in July 2005, with a reference level of 1000 and a baseline date of January 1st, 2001. The index is recalibrated every two years.
Nifty Pharma Scrip Selection Criteria
- The companies under evaluation must be Nifty 500 members.
- A shortfall amount of stocks will be chosen from the world of securities classified within the leading 800, predicated both on total daily turnover and daily total full market capitalization.
- Businesses must be engaged with the pharmaceutical industry.
- The company’s investing velocity in the previous six months must have been at least 90%.
- The company must have a six-month listing record. If a firm launches an IPO and meets the standard qualifying conditions for the index for a 3-month term rather than a period of 6 months, it will become qualified for inclusion within the index.
- Depending on the companies’ free-float market capitalization, the final 20 companies will be chosen.
- When making the final decision, priority will be given to firms that can be traded in the futures and options part of the NSE.
Other Indices
| Indices Name | Price | Price Change (% change) |
|---|---|---|
| India VIX | 17.39 | -1.25 (-6.71%) |
| Nifty 10 Yr Benchmark G-Sec | 2472.45 | 2.88 (0.12%) |
| Nifty 10 Yr Benchmark G-Sec (Clean Price) | 894.93 | 1.07 (0.12%) |
| Nifty 100 | 23772.5 | 76.25 (0.32%) |
| Nifty 100 Alpha 30 Index | 16850.2 | 122.25 (0.73%) |
Faqs
Which are currently the best pharma companies in India?
Cipla, Alkem, Sun Pharma, Torrent Pharma, and Dr. Reddy’s Laboratories are the current best pharma-based companies in India in terms of market capitalization.
How do I calculate Nifty Pharma?
Each stock’s weightage in the index is determined according to its free-float market capitalization, except for the top three stocks, whose combined weight cannot exceed 62% at the point of rebalancing (Index Rebalancing: The index is recalibrated every two years), and no separate stock should have a weightage greater than 33%.
How many companies are present in the Nifty 50 index?
The Nifty 50 Index comprises a total of 4 businesses from the Nifty Pharma Index. These companies are Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Divi’s Laboratories Ltd. and Sun Pharmaceuticals Ltd.
Is it risky to invest in pharma stocks?
Buying stocks of pharmaceutical companies can sometimes be risky due to the high costs and lengthy time between pharmaceutical research and approval (considering that the drug research procedure is successful and regulatory permission is given).
Should I start investing in pharmaceutical stocks?
Despite the instability, pharma businesses might be appealing to long-term traders. Traders can earn higher returns when they purchase at the correct time because the pharmaceutical industry is growing rapidly and has become increasingly important to daily life.
What is the cause behind the impulsive growth of the pharma sector?
Several pharma companies have experienced a spike in revenue due to authorities in the USA and other nations approving immunizations against the COVID-19 virus. The need for pharmaceutical stocks is rising; therefore, now is an excellent time to buy them.
What are the few major uses of Nifty Pharma?
There are several uses of Nifty Pharma in real-time. Still, the few major ones include the creation and implementation of structured products, index funds, ETFs, and benchmarking or evaluating mutual funds portfolios.
Latest News
- Jan 30, 2025
The HSBC Financial Services Fund - Direct (G) is an equity mutual fund that primarily invests in companies within the financial sector, including banking, insurance, asset management, and other financial services. Managed by HSBC Asset Management, the fund aims to generate long-term capital appreciation by leveraging opportunities in the evolving financial industry. It focuses on well-established financial institutions as well as emerging players poised for growth.
- Jan 30, 2025
Market analysts suggest that if the Finance Minister unveils growth-driven initiatives while adhering to fiscal discipline, the conditions could be favorable for a rate cut of 25-50 basis points in the RBI’s February policy meeting.
Latest Blogs
Navigating the many options for banking services becomes a crucial task for both individuals and enterprises as we enter the Indian financial scene. The top banks in India provide a wide range of services that extend beyond traditional banking, serving as cornerstones of the country's financial stability. These best banks in India offer individualized client care and state-of-the-art digital solutions that reflect the changing needs of the financial industry.
- Apr 14, 2025
As per the latest exchange notification (BSE Notice 20250129-25 dated 29th January 2025), all Mutual Funds will observe February 1, 2025 (Union Budget Day), as a Non-Business / Non-Transaction Day for all schemes.
- Jan 30, 2025
